|
Robert L. Jones is a partner in Cooley Godward Kronish's Business department. He has been located in the Firm's Palo Alto office since it opened in 1980. Previously, he served as the Firm's Business department chair from 2002 to 2004 and chair of the Firm's Life Sciences practice from 2000 to 2002.
Mr. Jones has a broad corporate law practice devoted to the representation of technology companies, and particularly companies in the life sciences industries. His practice includes the full range of corporate and securities law matters, including public and private financings, advice regarding disclosure issues and securities law compliance, and fiduciary issues.
Mr. Jones is one of the country's leading practitioners for the representation of biotechnology companies. He is particularly well known for his work in the field of licensing and corporate partnering transactions, and is a frequent lecturer of this topic. His biotechnology clients include, by way of example, Five Prime Therapeutics, Exelixis, Gilead Sciences, Kosan Biosciences, Nektar Therapeutics, and Onyx Pharmaceuticals. Mr. Jones was also the primary outside counsel for COR Therapeutics prior to its acquisition.
In 1979, Mr. Jones received a J.D. degree from Stanford Law School, where he was elected to Order of the Coif, and an M.B.A. degree from Stanford Graduate School of Business, where he received the Henry Ford II Scholar award for highest academic achievement. He also served as managing editor of the Stanford Journal of International Studies. Mr. Jones received a B.A. degree in 1975 from Swarthmore College, with a major in economics.
Mr. Jones is an Instructor of Management at the Stanford Graduate School of Business, where he teaches the course in Social and Ethical Issues in the Pharmaceutical and Biotechnology Industries.
Education- Stanford Law School
JD, 1979, Order of the Coif - Stanford University
MBA, 1979, Henry Ford II Scholar - Swarthmore College
BA Economics, 1975
Admissions
Memberships
|